Healthcare & Life Sciences

Latham offers life sciences and healthcare industry leaders deep sector knowledge, legal expertise, and commercial and government insight to meet client needs.

Why Latham

Melding Deep Industry Experience with Commercial Insight

Companies operating in the healthcare and life sciences sectors face an increasingly complex transactional, political, and competitive landscape. Latham’s superior grasp of the regulatory regimes and market issues means that clients can adroitly and expeditiously address litigation, mergers and acquisitions, capital raising, regulatory counseling, business restructuring and reorganization, contract negotiations, fraud and abuse compliance, white collar and government investigations, operational matters, and more.


For more information on Latham’s Healthcare experience and expertise visit the Healthcare Services & Providers Industry Group page

Life Sciences

For more information on Latham’s Life Sciences experience and expertise visit the Life Sciences Industry Group page

Awards & Rankings

  • Global Co-Chair Named Regulatory Trailblazer - May 06, 2018
  • Latham Partners Honored for Leadership in Los Angeles - November 02, 2017
  • Two Partners Among “Top 40 Under 40” in California - April 17, 2017
  • Ten Partners Honored as 2016 MVPs - January 04, 2017
  • Two New York Litigators Earn Recognition as “Rising Stars” - June 16, 2016

Latham is known for offering "expert representation across the full scope of matters affecting life sciences and healthcare clients, including providers." They have a "strong bench of former government attorneys who field expertise across numerous US departments and offices" and a "dominant presence in qui tam suits and criminal proceedings, as well as frequent involvement in complex transactions, including high-value M&A.”
— Chambers USA 2018


Webcast: Recent Developments in Health Care Enforcement

Media Coverage

Skilled in the Art: Zimmer Biomet Wins $13.3 Million Fee AwardZimmerBiomet Scores $13M In Fees In Howmedica IP FightTop Women Lawyers 2018: Judith Hasko


Latham & Watkins Advises Cotiviti Holdings in $4.9 Billion Acquisition by Verscend New York Litigation Team Earns Complete Victory for Aratana Therapeutics in Securities Class ActionGlobal Co-Chair Named Regulatory Trailblazer

Thought Leadership

OIG Provides Regulatory Considerations for Gainsharing Agreements in Advisory Opinion 17-09Policy Developments, Enforcement, and Priority Initiatives for 2018FDA Issues Draft Guidance on Orphan Drug Designation in Pediatric Subpopulations